Safranine T-Derived Activable Photosensitizer to Synergistically Regulate the RSS/ROS Dynamic Equilibrium for Boosted Photosensitization

Authors: Wang, Yafu; Wang, Yuqi; Yang, Xin; Song, Haoyang; Wang, Xiaoli; Niu, Huiyu; Jiang, Kai; James, Tony D; Yoon, Juyoung; Fan, Jiangli; Zhang, Hua; Peng, Xiaojun

Source journal: Angewandte Chemie (International ed. in English) (2026-11-20)

DOI: 10.1002/anie.7044325

Abstract

Photodynamic therapy (PDT) eliminates lesions like tumors via reactive oxygen species (ROS)-mediated oxidative damage. However, tumors overexpress reactive sulfur species (RSS) that scavenge cytotoxic ROS, endowing cancer cells with strong antioxidant resistance and weakening PDT efficacy. We fabricated a biosafe, readily available activatable photosensitizer ST-DNBS based on safranine T (ST). ST-DNBS selectively consumes RSS overexpressed in tumors and recovers photochemically active ST to produce massive ROS. For example, 6 microM ST‑DNBS depletes substantial glutathione (GSH), leading to a marked reduction in the characteristic absorbance of TNB(2-) (5-thio-2-nitrobenzoate dianion) at 412 nm in the DTNB (Ellman's reagent) assay relative to the control; ROS produced after 24 s of irradiation causes a 6.2-fold decrease in the UV absorbance of 1,3-diphenylisobenzofuran (DPBF). Tumor-activatable ST-DNBS depletes intracellular RSS to collapse tumor antioxidant systems, blocking ROS clearance and boosting intracellular ROS buildup. This RSS/ROS redox balance remodeling greatly enhances photodynamic activity, achieving a 90% tumor inhibition rate. Our RSS-scavenging, tumor-activated photosensitizer offers a practical strategy to overcome tumor antioxidant barriers and improve PDT antitumor performance.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.